Format

Send to

Choose Destination
See comment in PubMed Commons below
Korean J Pediatr. 2010 Aug;53(8):786-9. doi: 10.3345/kjp.2010.53.8.786. Epub 2010 Aug 31.

Disease-specific pluripotent stem cells.

Author information

1
Department of Pediatrics, Pediatric Epilepsy Clinics, Severance Children's Hospital, Epilepsy Research Institute, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. Recently, the generation of iPS cells from patients with a variety of genetic diseases was found to likely have a major impact on regenerative medicine, because these cells self-renew indefinitely in culture while retaining the capacity to differentiate into any cell type in the body, thereby enabling disease investigation and drug development. This review focuses on the current state of iPS cell technology and discusses the potential applications of these cells for disease modeling; drug discovery; and eventually, cell replacement therapy.

KEYWORDS:

Induced pluripotent stem cells; Transcription factors

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for The Korean Pediatric Society Icon for PubMed Central
    Loading ...
    Support Center